Daiwa Securities Group Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,003,000
-80.9%
1,000,000
-80.0%
0.01%
-80.0%
Q2 2022$5,261,000
+373.1%
5,000,000
+400.0%
0.04%
+471.4%
Q4 2021$1,112,0001,000,0000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ABSOLUTE INVESTMENT ADVISERS, LLC 3,500,000$3,675,0000.73%
SHENKMAN CAPITAL MANAGEMENT INC 11,052,000$11,459,0000.69%
TENOR CAPITAL MANAGEMENT Co., L.P. 14,416,000$15,218,0000.34%
WOLVERINE ASSET MANAGEMENT LLC 27,767,000$29,301,0000.29%
AQR Arbitrage LLC 5,200,000$5,486,0000.12%
CSS LLC/IL 2,500,000$2,635,0000.11%
CAPSTONE INVESTMENT ADVISORS, LLC 17,700,000$18,674,0000.09%
Jefferies Group LLC 10,096,000$10,674,5240.09%
Daiwa Securities Group Inc. 5,000,000$5,261,0000.04%
Calamos Advisors LLC 7,500,000$7,910,0000.03%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders